| 34.1991 -0.061 (-0.18%) | 09-29 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 41.25 |
1-year : | 42.4 |
| Resists | First : | 35.32 |
Second : | 36.3 |
| Pivot price | 34.06 |
|||
| Supports | First : | 33.72 | Second : | 28.06 |
| MAs | MA(5) : | 34.06 |
MA(20) : | 34.38 |
| MA(100) : | 33.6 |
MA(250) : | 31.07 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 26.8 |
D(3) : | 20 |
| RSI | RSI(14): 46.1 |
|||
| 52-week | High : | 36.72 | Low : | 27.08 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TMED ] has closed below upper band by 35.8%. Bollinger Bands are 58.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 34.3 - 34.47 | 34.47 - 34.61 |
| Low: | 33.37 - 33.6 | 33.6 - 33.79 |
| Close: | 33.87 - 34.23 | 34.23 - 34.51 |
TMED actively invests in securities of health care companies located mainly in the US but may also include foreign companies as well. Health care companies include a wide range such as biotechnology, pharmaceuticals, products and device providers, and health care service companies. Firms must be classified in the MSCI GICS health care sector. The fund employs a fundamental, bottom-up analysis and can invest in companies across any market capitalization using both growth and value strategies, typically focusing on 100-150 stocks. This includes the use of derivatives related to the fund's investment focus. The funds management team aims to outperform its respective sector index.
Thu, 16 Jul 2026
UnitedHealth rallies on upbeat forecast; these ETFs have the highest exposure (UNH:NYSE) - Seeking Alpha
Tue, 28 Apr 2026
The case for active sector ETFs in an AI-driven economy - T. Rowe Price
Tue, 13 Jan 2026
EIKN Stock Price and Chart — NASDAQ:EIKN - TradingView
Sat, 05 Jul 2025
T. Rowe Price Health Care ETF (TMED) Performance History - ca.finance.yahoo.com
Fri, 13 Jun 2025
Corporate Roundup: Retirement and Wealth Management - 401k Specialist
Thu, 12 Jun 2025
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |